Tracking transplanted retinal cells to improve vision restoration
Official title: Nanoparticle-Based Tracking of Retinal Ganglion Cell Transplant
Funded at Case Western Reserve University · NIH-11259044 · Data updated 2026-11-12
This study is looking at how tiny particles can help doctors see and track transplanted cells in the eye, which could lead to better treatments for people with retinal diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project start | July 1, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $249,000 |
| NIH project number | 4R00EY034168-03 |
| Project ID | NIH-11259044 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from degenerative retinal conditions, such as glaucoma or age-related macular degeneration.
✕Less likely to help
Patients with non-degenerative eye conditions or those who do not have retinal ganglion cell damage may not benefit from this research.
What this research studies
This research focuses on improving cell transplant therapies for retinal diseases by using nanoparticles to track retinal ganglion cells (RGCs) in real-time. The approach involves customizing nanoparticles to enhance imaging techniques, allowing researchers to visualize and monitor the behavior of transplanted cells in the eye. By understanding how these cells behave and the factors affecting their success, the research aims to optimize transplant procedures and improve outcomes for patients with degenerative eye conditions.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for vision loss caused by retinal diseases.
How similar studies have gone: Previous research has shown promise in using nanoparticle-based imaging techniques for tracking cellular therapies, indicating a potential for success in this novel application.
Where this research is happening
-
Case Western Reserve University
Cleveland, United States Active
Researchers
- Principal investigator: Chen, Fang — Case Western Reserve University
- Study coordinator: Chen, Fang
Related research
Other NIH-funded projects on the same topics.
-
Targeting early oral GVHD to improve mouth health after stem cell transplant
A study at UW–Madison will explore why some transplant patients develop painful oral GVHD and test ideas to prevent and lessen mouth-related problems.
-
Innate and Adaptive Immunoregulation in Liver Transplant Ischemia/Reperfusion Injury
A liver transplant-focused project investigates how the body’s early and later immune responses affect transplant failure or success after reperfusion.
-
Exercise-based frailty program for people awaiting lung transplants
A tailored exercise and lifestyle program is being tested to reduce frailty and improve outcomes for people waiting for a lung transplant.
-
Diabetes and Donor Tissue in Corneal Transplants
This grant studies whether corneas from donors with diabetes affect the success of Descemet membrane endothelial keratoplasty (DMEK) and what factors predict better or worse outcomes.
-
Microbial clues to diagnose and predict infections in kidney transplant patients
A patient-focused project will look for microbial biomarkers in stool, blood, and urine to help doctors predict and diagnose infections in people who have had a kidney transplant.
-
Medicare Advantage and Transplant Access for Rural and Vulnerable Communities
Aimed at understanding how Medicare Advantage affects early steps to kidney transplant for adults in rural or socioeconomically challenged groups.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.